| Menopause |
1 |
1 |
| Breast Cancer |
0 |
1 |
| Cancer |
0 |
0.68 |
| Ovarian Cancer |
0 |
0.63 |
| Breast |
0 |
0.55 |
| Cancer Risk |
0 |
0.55 |
| Lung Cancer |
0 |
0.5 |
| Estrogen |
0 |
0.36 |
| Contraception |
0 |
0.19 |
| Hysterectomy |
0 |
0.18 |
| Oophorectomy |
0 |
0.18 |
| Progestin |
0 |
0.18 |
| Cerebrovascular Accident |
0 |
0.11 |
| Thromboembolism |
0 |
0.11 |
| Cardiovascular Risk Management |
0 |
0.1 |
| Coronary Artery Disease (CAD) |
0 |
0.08 |
| Surgery |
0 |
0.08 |
| Gynecologic Surgery |
0 |
0.07 |
| Obesity |
0 |
0.07 |
| Heart |
0 |
0.05 |
| Hormonal Therapy |
0 |
0.04 |
| Transdermal |
0 |
0.04 |
| Uterus |
0 |
0.04 |
| Cognitive Impairment |
0 |
0.03 |
| Revenue and Practice Management |
0 |
0.03 |
| Bone |
0 |
0.02 |
| BRCA |
0 |
0.02 |
| Dementia |
0 |
0.02 |
| Health Insurance |
0 |
0.02 |
| Impairment |
0 |
0.02 |
| Insurance |
0 |
0.02 |
| Mild Cognitive Impairment |
0 |
0.02 |
| Osteoporosis |
0 |
0.02 |
| Ovary |
0 |
0.02 |
| Pain Management |
0 |
0.02 |
| Pregnancy |
0 |
0.02 |
| Thrombosis |
0 |
0.02 |
| Vagina |
0 |
0.02 |
| Abscess |
0 |
0.01 |
| Adverse Effects |
0 |
0.01 |
| Allergy |
0 |
0.01 |
| Biopsy |
0 |
0.01 |
| Cardiovascular disease |
0 |
0.01 |
| Clinical Research |
0 |
0.01 |
| Ectopic Pregnancy |
0 |
0.01 |
| Endometriosis |
0 |
0.01 |
| Epidemiology |
0 |
0.01 |
| Epithelium |
0 |
0.01 |
| Florida |
0 |
0.01 |
| Generics |
0 |
0.01 |
| Healthcare and Medical Technology |
0 |
0.01 |
| Lung |
0 |
0.01 |
| Match |
0 |
0.01 |
| Metabolism |
0 |
0.01 |
| Minnesota |
0 |
0.01 |
| Oophoritis |
0 |
0.01 |
| Pain |
0 |
0.01 |
| Parkinson Disease |
0 |
0.01 |
| Parkinsonian |
0 |
0.01 |
| Patient Safety |
0 |
0.01 |
| Peanut Allergy |
0 |
0.01 |
| Pelvic Pain |
0 |
0.01 |
| Quality of Life |
0 |
0.01 |
| Salpingectomy |
0 |
0.01 |
| Stroke Risk |
0 |
0.01 |
| Thrombotic Stroke |
0 |
0.01 |
| UK Site Content |
0 |
0.01 |
| Venous Thromboembolism (VTE) |
0 |
0.01 |